Suppr超能文献

绘制并驱动干细胞生态系统。

Mapping and driving the stem cell ecosystem.

作者信息

Knoepfler Paul S

机构信息

Department of Cell Biology & Human Anatomy, University of California, Davis, 1 Shields Ave, Davis, CA 95616, USA.

Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children Northern California, Sacramento, CA 95817, USA.

出版信息

Regen Med. 2018 Oct;13(7):845-858. doi: 10.2217/rme-2018-0056. Epub 2018 Oct 5.

Abstract

The stem cell and regenerative medicine arena has become increasingly complicated in recent years with thousands of people involved. There are as many as a dozen or more main groups of stakeholders, who together may be viewed as one ecosystem that is now rapidly evolving. The nature of the ecosystem and its evolution have major implications for not just those within it, but also for medicine and society at large. Here, I describe this ecosystem and its evolution, as well as the negative impacts within the ecosystem of a constellation of hundreds of unproven for-profit clinics and related businesses. Finally, I propose approaches for how to positively influence and drive the future of the global stem cell ecosystem.

摘要

近年来,随着数千人参与其中,干细胞与再生医学领域变得愈发复杂。利益相关者多达十几个甚至更多主要群体,他们共同构成了一个如今正在迅速演变的生态系统。这个生态系统的性质及其演变不仅对其中的参与者,而且对整个医学和社会都具有重大影响。在此,我将描述这个生态系统及其演变,以及数百个未经证实的营利性诊所和相关企业所构成的群体在该生态系统内产生的负面影响。最后,我提出了如何积极影响并推动全球干细胞生态系统未来发展的方法。

相似文献

1
Mapping and driving the stem cell ecosystem.
Regen Med. 2018 Oct;13(7):845-858. doi: 10.2217/rme-2018-0056. Epub 2018 Oct 5.
2
Texas H.B. 810: Increased Access to Stem Cell Interventions or an Increase in Unproven Treatments?
Stem Cells Dev. 2018 Nov 1;27(21):1463-1465. doi: 10.1089/scd.2018.0148. Epub 2018 Sep 8.
3
Rejuvenating Regenerative Medicine Regulation.
N Engl J Med. 2018 Feb 8;378(6):504-505. doi: 10.1056/NEJMp1715736. Epub 2018 Jan 10.
5
FDA challenges stem-cell clinic.
Nature. 2010 Aug 19;466(7309):909. doi: 10.1038/466909a.
6
From bench to FDA to bedside: US regulatory trends for new stem cell therapies.
Adv Drug Deliv Rev. 2015 Mar;82-83:192-6. doi: 10.1016/j.addr.2014.12.001. Epub 2014 Dec 7.
7
Rapid change of a cohort of 570 unproven stem cell clinics in the USA over 3 years.
Regen Med. 2019 Aug;14(8):735-740. doi: 10.2217/rme-2019-0064. Epub 2019 Aug 28.
8
Evaluating the FDA regenerative medicine framework: opportunities for stakeholders.
Regen Med. 2020 Jul;15(7):1825-1832. doi: 10.2217/rme-2020-0073. Epub 2020 Aug 20.
9
Reflection on the enactment and impact of safety laws for regenerative medicine in Japan.
Stem Cell Reports. 2021 Jun 8;16(6):1425-1434. doi: 10.1016/j.stemcr.2021.04.017. Epub 2021 May 20.
10
FDA scrutinizes human stem cell therapies.
Nat Biotechnol. 2008 Jun;26(6):598-9. doi: 10.1038/nbt0608-598.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验